We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-9%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$190M
AUM Growth
-$46.3M
Cap. Flow
-$23.9M
Cap. Flow %
-12.58%
Top 10 Hldgs %
46.87%
Holding
49
New
14
Increased
5
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$7.1M
2
WAT icon
Waters Corp
WAT
+$5.12M
3
A icon
Agilent Technologies
A
+$4.79M
4
ABBV icon
AbbVie
ABBV
+$4.6M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.91M

Sector Composition

Rank Sector Weight
1 Healthcare 85.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
26
Cigna
CI
$73.3B
$3.31M 1.75%
+12,000
New +$3.83M
BIO icon
27
Bio-Rad Laboratories Class A
BIO
$9.58B
$3.29M 1.73%
+10,000
New +$3.39M
SNN icon
28
Smith & Nephew
SNN
$12.5B
$3.07M 1.62%
125,000
-15,000
-11% -$398K
SEM
29
DELISTED
Select Medical
SEM
$2.83M 1.49%
150,000
-109,840
-42% -$2.12M
ZTS icon
30
Zoetis
ZTS
$30.4B
$2.44M 1.29%
+15,000
New +$2.68M
ZBH icon
31
Zimmer Biomet
ZBH
$18.4B
$2.11M 1.11%
20,000
-20,000
-50% -$2.15M
ACHC icon
32
Acadia Healthcare
ACHC
$2.96B
$1.98M 1.04%
50,000
-65,000
-57% -$2.93M
BNTX icon
33
BioNTech
BNTX
$23.4B
$1.71M 0.9%
+15,000
New +$1.71M
ALNY icon
34
Alnylam Pharmaceuticals
ALNY
$30B
$1.65M 0.87%
+7,000
New +$1.84M
RGEN icon
35
Repligen
RGEN
$9.39B
$1.44M 0.76%
10,000
-15,000
-60% -$2.15M
MDGL icon
36
PUT
Madrigal Pharmaceuticals
MDGL
$12.4B
$1.23M 0.65%
+4,000
New +$1.13M
SRPT icon
37
Sarepta Therapeutics
SRPT
$1.95B
$1.22M 0.64%
+10,000
New +$1.23M
MRVI icon
38
Maravai LifeSciences
MRVI
$867M
$763K 0.4%
140,000
-285,000
-67% -$1.83M
ASND icon
39
Ascendis Pharma A/S
ASND
$16.8B
-10,000
Closed -$1.49M
BAX icon
40
Baxter International
BAX
$14B
-150,000
Closed -$5.7M
BDX icon
41
Becton Dickinson
BDX
$49.7B
-25,000
Closed -$6.03M
ISRG icon
42
Intuitive Surgical
ISRG
$142B
-17,500
Closed -$9.11M
MDT icon
43
Medtronic
MDT
$116B
-60,000
Closed -$5.4M
RVTY icon
44
Revvity
RVTY
$13B
-40,000
Closed -$5.11M
STVN icon
45
Stevanato
STVN
$5.81B
-140,000
Closed -$2.8M
TEVA icon
46
Teva Pharmaceuticals
TEVA
$42.9B
-170,000
Closed -$3.06M
WST icon
47
West Pharmaceutical
WST
$24.7B
-17,000
Closed -$5.1M

Similar funds

Sivik Global Healthcare's Q4 2024 Portfolio in Review

As of Q4 2024, Sivik Global Healthcare held 49 positions worth $190M, down 20% from $236M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sivik Global Healthcare withdrew a net $23.9M in Q4 2024, closing 11 positions and reducing 17 holdings. Its most notable exit was Intuitive Surgical, an estimated $9.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in UnitedHealth worth $6.32M.

  • Sivik Global Healthcare's largest Q4 2024 buy was UnitedHealth: 12,500 shares worth $6.32M.
  • Sivik Global Healthcare added most to Humana in Q4 2024, an estimated $2.68M increase.
  • Sivik Global Healthcare's biggest Q4 2024 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $9.69M.
  • Sivik Global Healthcare fully exited Intuitive Surgical in Q4 2024, selling an estimated $9.11M.
  • Sivik Global Healthcare's ten largest holdings make up 47% of its $190M portfolio in Q4 2024.
  • Sivik Global Healthcare opened 14 new positions and closed 11 in Q4 2024.
  • Sivik Global Healthcare's portfolio value fell 20% quarter-over-quarter to $190M.

Based on Sivik Global Healthcare's 13F filing for Q4 2024, filed 23 Jan 2025.